IL1B and Stroke: IL-1RA treatment to dampen IL-1 signalling has previously proven neuroprotective in animal models of both stroke [31, 42, 46, 47] and TBI [28–30], leading to its progression into human clinical trials for these acquired CNS injuries [48–50].